Most people with peripheral artery disease, PAD, have great difficulty walking and few treatments to help. Preliminary results of a new Northwestern Medicine study suggest that cocoa may have a therapeutic effect on walking performance in people with PAD. Dr. Mary McDermott led this study and shares the results.
An important finding detailed in a new Northwestern Medicine study warns of the role certain kinds of meat may play in increasing cardiovascular disease risk and premature death. Norrina Allen, PhD, led this research and shares details about the study.
The outbreak of a novel Coronavirus in China is making headlines around the world. Here at Northwestern, microbiologist Karla Satchell, PhD, is leading an effort to investigate the structure biology of the components of the virus to ultimately understand how to stop it from replicating in human cells through a medication or vaccine.
A new study led by Nina Kraus, PhD, has found that athletes have healthier brains than non-athletes.
Northwestern Medicine cardiologists Clyde Yancy, MD, and Donald Lloyd-Jones, MD, share tips to lose weight or maintain weight and live longer, healthier lives in 2020.
Two Northwestern physician-scientists, Clyde Yancy, MD, and Donald Lloyd-Jones, MD, share their thoughts on the latest findings and advances in cardiology to come in 2020.
It is the most common tumor found in women and is the cause of 200,000 hysterectomies in the United States every year. Yet, uterine fibroids have not been a frequent topic of medical research. Northwestern’s Serdar Bulun, MD, leads one of the few research programs focused on the molecular and cellular abnormalities that may cause uterine fibroids and is investigating novel targets to treat the condition.
In a recent Northwestern Medicine study published in the New England Journal of Medicine, female surgical residents reported more mistreatment than men, which was linked to a higher burnout rates and more suicidal thoughts. Study authors Karl Bilimoria, MD & Yue-Yung Hu, MD explain.
Elizabeth McNally, MD, PhD, talks about her recent discoveries in the genetics of cardiovascular and neuromuscular disorders and what we can expect in the next few years in the field of genetic medicine.
For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern’s Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.